Researchers
Jeremić, Aleksandra
Results 1-12 of 12
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | Perceived stress four weeks after initiation of escitalopram monotherapy as a predictor of anxiolytic and antidepressant effects![]() | Vuković, Petar | Article | 21aM21a |
| 2025 | Efficacy of individualized escitalopram dosing based on plasma level monitoring: findings from a cross-sectional study | Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2025 | Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study![]() | Vuković, Petar G. | Article | 21M21 |
| 2024 | Effectiveness and safety of personalized escitalopram treatment based on therapeutic monitoring of drug's plasma concentration - a prospective cohort study![]() | Vuković, P.; Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2024 | Evaluation of the efficacy of individualised escitalopram dosing based on plasma level monitoring: findings from a cross-sectional study![]() | Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2024 | Association between escitalopram dose personalisation based on quantification of drug plasma levels and the outcome of escitalopram treatment![]() | Vuković, Petar G.; Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2023 | Impact of personalised dosing based on quantification of drug plasma levels on the efficacy and safety of treatment with escitalopram![]() | Vuković, P.; Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2023 | Impact of personalized dosing guided by plasma level quantification on escitalopram exposure - a cross-sectional study![]() | Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2022 | Association between CYP2C19 genotype and body weight with escitalopram exposure – a cross sectional study![]() | Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2022 | Effects of personalized dosing based on drug plasma level quantification on effectiveness and safety of escitalopram treatment![]() | Vuković, Petar | Conference Paper | Mp. category will be shown later |
| 2022 | Patients’ and psychiatrists’ stance on the current state of pharmacological depression treatment in Serbia and prospects of introduction of personalized pharmacotherapy and its potential effects | Jeremić, Aleksandra | Article | 52M52 |
| 2021 | Validation of a quick and simple chromatographic method for simultaneous quantification of sertraline, escitalopram, risperidone and paliperidone levels in the human plasma | Jeremić, Aleksandra | Article | 52M52 |
